Showing results (141-150 of 226) with videos related to
Sort By:
Pageof 23
Angiology|November 28, 2018
Evaluation of Risk Factors for Limb-Specific Peripheral Vascular Events in Patients With Peripheral Artery Disease: A Post Hoc Analysis of the SEASON Prospective Observational StudyTetsuro Miyata, Yukihito Higashi, Hiroshi Shigematsu, et al.Anticancer Research|January 31, 2012
A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemiaToshihiro Fukushima, Yoshimasa Urasaki, Masaki Yamaguchi, et al.Journal of Atherosclerosis and Thrombosis|October 16, 2018
Cumulative Effects of LDL Cholesterol and CRP Levels on Recurrent Stroke and TIAKazuo Kitagawa, Naohisa Hosomi, Yoji Nagai, et al.Modern Rheumatology|May 21, 2014
Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studiesTsutomu Takeuchi, Kazuhiko Yamamoto, Hisashi Yamanaka, et al.European Heart Journal|April 7, 2009
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)Hiroshi Kasanuki, Nobuhisa Hagiwara, Saichi Hosoda, et al.American Heart Journal|February 5, 2004
Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trialMasatsugu Hori, Shigetake Sasayama, Akira Kitabatake, et al.Journal of Atherosclerosis and Thrombosis|September 20, 2019
Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARSNaohisa Hosomi, Kazuo Kitagawa, Yoji Nagai, et al.Journal of Atherosclerosis and Thrombosis|September 20, 2017
Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke EventNaohisa Hosomi, Yoji Nagai, Kazuo Kitagawa, et al.Heart and Vessels|March 17, 2021
Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND studyHirotsugu Atarashi, Shinichiro Uchiyama, Hiroshi Inoue, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|January 27, 2005
Effects of the endothelin receptor antagonist bosentan on hemodynamics, symptoms and functional capacity in Japanese patients with severe pulmonary hypertensionShigetake Sasayama, Takeyoshi Kunieda, Hitonobu Tomoike, et al.Pageof 23